RNA Interference News and Research

RSS
Ipsen partners with IMCB to advance understanding and research of Botulinum Neurotoxin Biology

Ipsen partners with IMCB to advance understanding and research of Botulinum Neurotoxin Biology

Researchers develop novel ss-siRNAs to turn off disease-related genes

Researchers develop novel ss-siRNAs to turn off disease-related genes

High-throughput RNA interference screen identifies potential drug target against henipaviruses

High-throughput RNA interference screen identifies potential drug target against henipaviruses

Four key genes govern growth, multiplication of blood stem cells

Four key genes govern growth, multiplication of blood stem cells

Johns Hopkins Greenberg Bladder Cancer Institute awards grants for 10 bladder cancer research projects

Johns Hopkins Greenberg Bladder Cancer Institute awards grants for 10 bladder cancer research projects

New TAU study offers tangible hope of curing Mantle Cell Lymphoma

New TAU study offers tangible hope of curing Mantle Cell Lymphoma

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

Set of genes identified in human genome essential for survival, proliferation of human cell lines

Set of genes identified in human genome essential for survival, proliferation of human cell lines

Lonza, Benitec partner to develop scalable manufacturing process for AAV-based viral gene therapies

Lonza, Benitec partner to develop scalable manufacturing process for AAV-based viral gene therapies

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

RAB35 protein plays role in oncogenic process

RAB35 protein plays role in oncogenic process

Regen BioPharma implements gene silencing technology in killing cancer stem cells

Regen BioPharma implements gene silencing technology in killing cancer stem cells

Benitec, ReNeuron collaborate to launch new exploratory cellular therapy program

Benitec, ReNeuron collaborate to launch new exploratory cellular therapy program

Discovery may help scientists attack the root of deadliest brain tumors

Discovery may help scientists attack the root of deadliest brain tumors

RXi Pharmaceuticals receives Notice of Allowance from USPTO for novel, self-delivering RNAi platform

RXi Pharmaceuticals receives Notice of Allowance from USPTO for novel, self-delivering RNAi platform

UC Santa Cruz-led study offers new insights into molecular mechanisms of biological clock

UC Santa Cruz-led study offers new insights into molecular mechanisms of biological clock

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

MGH investigators identify inflammatory molecule that plays key role in lupus

MGH investigators identify inflammatory molecule that plays key role in lupus

PARP inhibitors can be effective in broader group of patients

PARP inhibitors can be effective in broader group of patients

CRISPR-Cas9 gene-editing technology targets every gene in the genome in animal cancer model

CRISPR-Cas9 gene-editing technology targets every gene in the genome in animal cancer model